Immunogenicity, reactogenicity and safety of 2 doses of an adjuvanted herpes zoster subunit vaccine administered 2, 6 or 12 months apart in older adults: Results of a phase III, randomized, open-label, multicenter study.
Saved in:
| Title: | Immunogenicity, reactogenicity and safety of 2 doses of an adjuvanted herpes zoster subunit vaccine administered 2, 6 or 12 months apart in older adults: Results of a phase III, randomized, open-label, multicenter study. |
|---|---|
| Authors: | Lal, Himal1 himallal@yahoo.com, Poder, Airi2 airi.poder@std.ee, Campora, Laura3 laura.e.campora@gsk.com, Geeraerts, Brecht3 brecht.r.geeraerts@gsk.com, Oostvogels, Lidia3 lidia.oostvogels@gsk.com, Vanden Abeele, Carline3 carline.c.vanden-abeele@gsk.com, Heineman, Thomas C.1 thomas.heineman@genocea.com |
| Source: | Vaccine. Jan2018, Vol. 36 Issue 1, p148-154. 7p. |
| Database: | Environment Complete |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: eih DbLabel: Environment Complete An: 126896314 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Immunogenicity, reactogenicity and safety of 2 doses of an adjuvanted herpes zoster subunit vaccine administered 2, 6 or 12 months apart in older adults: Results of a phase III, randomized, open-label, multicenter study. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Lal%2C+Himal%22">Lal, Himal</searchLink><relatesTo>1</relatesTo><i> himallal@yahoo.com</i><br /><searchLink fieldCode="AR" term="%22Poder%2C+Airi%22">Poder, Airi</searchLink><relatesTo>2</relatesTo><i> airi.poder@std.ee</i><br /><searchLink fieldCode="AR" term="%22Campora%2C+Laura%22">Campora, Laura</searchLink><relatesTo>3</relatesTo><i> laura.e.campora@gsk.com</i><br /><searchLink fieldCode="AR" term="%22Geeraerts%2C+Brecht%22">Geeraerts, Brecht</searchLink><relatesTo>3</relatesTo><i> brecht.r.geeraerts@gsk.com</i><br /><searchLink fieldCode="AR" term="%22Oostvogels%2C+Lidia%22">Oostvogels, Lidia</searchLink><relatesTo>3</relatesTo><i> lidia.oostvogels@gsk.com</i><br /><searchLink fieldCode="AR" term="%22Vanden+Abeele%2C+Carline%22">Vanden Abeele, Carline</searchLink><relatesTo>3</relatesTo><i> carline.c.vanden-abeele@gsk.com</i><br /><searchLink fieldCode="AR" term="%22Heineman%2C+Thomas+C%2E%22">Heineman, Thomas C.</searchLink><relatesTo>1</relatesTo><i> thomas.heineman@genocea.com</i> – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22Vaccine%22">Vaccine</searchLink>. Jan2018, Vol. 36 Issue 1, p148-154. 7p. |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=eih&AN=126896314 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.vaccine.2017.11.019 Languages: – Code: eng Text: English PhysicalDescription: Pagination: PageCount: 7 StartPage: 148 Titles: – TitleFull: Immunogenicity, reactogenicity and safety of 2 doses of an adjuvanted herpes zoster subunit vaccine administered 2, 6 or 12 months apart in older adults: Results of a phase III, randomized, open-label, multicenter study. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Lal, Himal – PersonEntity: Name: NameFull: Poder, Airi – PersonEntity: Name: NameFull: Campora, Laura – PersonEntity: Name: NameFull: Geeraerts, Brecht – PersonEntity: Name: NameFull: Oostvogels, Lidia – PersonEntity: Name: NameFull: Vanden Abeele, Carline – PersonEntity: Name: NameFull: Heineman, Thomas C. IsPartOfRelationships: – BibEntity: Dates: – D: 02 M: 01 Text: Jan2018 Type: published Y: 2018 Identifiers: – Type: issn-print Value: 0264410X Numbering: – Type: volume Value: 36 – Type: issue Value: 1 Titles: – TitleFull: Vaccine Type: main |
| ResultId | 1 |
